Basiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3046|1397-3142|7|E165-E169

ISSN： 1397-3142

Source： PEDIATRIC TRANSPLANTATION, Vol.1397-3142, Iss.7, 2015-11, pp. : E165-E169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 22, Iss. 9, 2016-09 ,pp. : 1275-1283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Group visits in the pediatric heart transplant outpatient clinic

By  

PEDIATRIC TRANSPLANTATION, Vol. 1397-3142, Iss. 7, 2015-11 ,pp. : 730-736

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychosocial functioning in pediatric heart transplant recipients and their families

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clostridium difficile infection in the pediatric transplant patient

By  

PEDIATRIC TRANSPLANTATION, Vol. 1397-3142, Iss. 7, 2015-11 ,pp. : 792-798

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pediatric patient with end‐stage kidney disease secondary to Eagle‐Barrett syndrome and metastatic unresectable hepatoblastoma treated successfully with chemotherapy and liver‐kidney transplant

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite